KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.41 $2.35 Friday, 26th Apr 2024 CYCC stock ended at $1.51. This is 5.63% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.85% from a day low at $1.46 to a day high of $1.56.
90 days $1.41 $3.08
52 weeks $1.41 $13.20

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
May 06, 2020 $4.21 $4.30 $4.03 $4.06 504 475
May 05, 2020 $4.27 $4.39 $4.15 $4.16 1 019 654
May 04, 2020 $4.06 $4.24 $4.03 $4.18 718 916
May 01, 2020 $4.18 $4.18 $4.00 $4.08 400 983
Apr 30, 2020 $4.06 $4.23 $3.96 $4.17 932 883
Apr 29, 2020 $4.10 $4.13 $3.96 $4.02 754 912
Apr 28, 2020 $4.20 $4.21 $4.02 $4.09 675 745
Apr 27, 2020 $4.29 $4.30 $3.99 $4.15 1 594 810
Apr 24, 2020 $3.92 $4.02 $3.88 $4.02 925 950
Apr 23, 2020 $3.99 $4.02 $3.85 $3.98 888 423
Apr 22, 2020 $4.17 $4.18 $3.85 $4.01 1 480 048
Apr 21, 2020 $4.15 $4.46 $4.02 $4.12 6 606 472
Apr 20, 2020 $9.49 $19.25 $8.35 $8.64 12 064 452
Apr 17, 2020 $6.80 $7.29 $6.27 $6.27 40 732
Apr 16, 2020 $8.56 $8.75 $6.45 $6.80 79 186
Apr 15, 2020 $6.00 $11.44 $6.00 $7.97 235 884
Apr 14, 2020 $0.400 $0.404 $0.361 $0.387 374 645
Apr 13, 2020 $0.400 $0.400 $0.380 $0.400 83 306
Apr 09, 2020 $0.410 $0.420 $0.381 $0.390 56 209
Apr 08, 2020 $0.410 $0.410 $0.350 $0.400 86 924
Apr 07, 2020 $0.380 $0.400 $0.370 $0.375 34 697
Apr 06, 2020 $0.350 $0.400 $0.350 $0.380 46 809
Apr 03, 2020 $0.380 $0.380 $0.350 $0.372 35 537
Apr 02, 2020 $0.382 $0.382 $0.360 $0.361 16 791
Apr 01, 2020 $0.385 $0.385 $0.340 $0.370 31 923
Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT